arrow
T

Thomas Longerich

Ruprecht Karls University Heidelberg
H指数:65
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy

癌症驱动因子无关的靶向扩增表面蛋白,鉴定MPZL1用于选择性CAR-T细胞疗法

2026-09-100
OAAI
Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescence

作者更正:由炎症小体调控的复杂分泌程序控制旁分泌衰老

2026-04-280
PRE
Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study☆

胆道癌中生物标志物检测的临床实践与意义:一项观察性研究☆

2025-11-040
OAAI
ASO Visual Abstract: Beta-Blockers Influence Oncological Outcomes in Patients with Gastric Cancer Treated with Neoadjuvant Chemotherapy on the Basis of the Pathological Subtype-A Retrospective Cohort Study

ASO视觉摘要:基于病理亚型,新辅助化疗治疗的胃癌患者中β-阻滞剂影响肿瘤学结局——一项回顾性队列研究

2025-05-030
PRE
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer

碳离子立体定向放疗作为原发性肝癌患者的局部消融治疗

2025-02-180
OAAI
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR a and PCK1

5:2间歇性禁食方案可通过肝脏PPAR A和PCK1改善NASH和纤维化并延缓HCC的发展

2024-06-0112
OAAI
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial
2024-06-010
OAAI
Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication
2024-03-045
OAAI